在非睡眠阻塞性睡眠呼吸暂停患者中,CPAP对二次心血管结果的个性化治疗效应
Oren Cohen1, Zainab Al-Taie2, Vaishnavi Kundel1
1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Communications medicine
|March 14, 2026
概括
持续的正气道压力 (CPAP) 可能有利于一些患有阻塞性睡眠呼吸暂停 (OSA) 的患者,而有害于其他人. 对SAVE试验的因果分析揭示了CPAP中的显著个体差异.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 生物统计学 生物统计学
背景情况:
- 持续正气道压力 (CPAP) 是阻塞性睡眠呼吸暂停 (OSA) 的标准治疗方法.
- 以前的试验并没有明确表明CPAP对心血管的益处.
- 喘可能是一种异质的疾病,需要个性化的治疗方法.
研究的目的:
- 研究CPAP对OSA患者心血管结果的个性化治疗效应.
- 为了确定受益或受损于CPAP治疗的患者子组.
主要方法:
- 对来自SAVE试验 (n=2,687) 的数据进行了因果生存森林分析.
- 对于每个参与者来说,估计了个性化治疗效果得分.
- 分析的重点是预测CPAP的不同反应.
主要成果:
- 在CPAP治疗反应中观察到显著的异质性.
- 预计受益的患者在使用CPAP时,无事件生存率提高了100倍.
- 预计会受到伤害的患者,心血管不良结果增加了100倍以上.
结论:
- 这项研究为OSA中CPAP的个性化治疗效果估计提供了第一个证据.
- 精准医学方法可以指导CPAP治疗决策.
- 个性化治疗可以降低心血管风险,并预防易受OSA患者的伤害.
相关概念视频
Sleep Apnea
713
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
713
Mechanical Ventilation III: Noninvasive Ventilation
747
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
747
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
714
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
714
Heart Failure VI: Adjunct Therapies
498
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
498
Cardiopulmonary Resuscitation II: ACLS Airway Management
898
Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
898
Cardiomyopathy III: Hypertrophic Cardiomyopathy
611
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611


